The JAK/STAT signaling pathway plays a key role in regulating immune responses and inflammation, and its dysregulation has been implicated in the pathogenesis of CTCL (71–74). This evidence concerns the gene SOAT1 and primary cutaneous T-cell non-Hodgkin lymphoma.